Introduction
Nurses, as the largest body of healthcare professionals, played a critical role during the COVID-19 pandemic (Asadi et al., 2019; Mira et al., 2020; Salari et al., 2020). The outbreak imposed significant mental strain, including anxiety, depression, insomnia, and chronic stress (Lasalvia et al., 2021). A meta-analysis reported an anxiety prevalence of 23% among health workers (Pappa et al., 2020), with nurse-specific rates ranging from 33% in Italy (Simonetti et al., 2021), 43% in China (Chen et al., 2022b), 44–73% in Iran (Sharifi et al., 2022), and nearly 54% in Portugal (De Pinho et al., 2021). Anxiety, which is defined as fear of future threats (Cohen et al., 2016), may progress to depression if persistent (Crocq, 2015).
Stressed nurses are more susceptible to mental illness, poor concentration, absenteeism, burnout, substance abuse, and weakened immunity (Amiri et al., 2021). Sleep disturbances, reported by 96% of nurses during the pandemic (Salaree et al., 2022), are widespread globally—60% in China (Qiu et al., 2020), 75% in Bahrain (Jahrami et al., 2021), and 71% in Italy (Simonetti et al., 2021). These issues have long-lasting consequences, including gastrointestinal disorders, fatigue, emotional instability, and reduced professional performance (Huang et al., 2020; Hoseinabadi, 2020). Therefore, supporting nurses’ physical and psychological health is vital to sustaining healthcare delivery and minimizing the broader impact of infectious diseases.
Common treatments for anxiety and sleep problems include both pharmaceutical and herbal approaches. Serotonergic medications can relieve symptoms but often cause unwanted side effects, such as sexual dysfunction, weight gain, and drug withdrawal (Patel et al., 2016). In contrast, herbal remedies may offer safer and more culturally grounded alternatives. Clinical research on herbal medicine as complementary and alternative medicine (CAM) has so far demonstrated positive outcomes (Khalafi-Kheydani et al., 2022; Maghami et al., 2023; Banihashemi et al., 2025).
Astragalus membranaceus, a widely used plant in Iranian traditional medicine, shows promise in treating stress-related disorders. Known locally as radix Astragali, the root has been used to regulate heart function, sleep quality, hormonal balance, and overall health (Shahrajabian et al., 2019; Peng et al., 2022). This plant may contribute to the improvement of sleep disorders through its physiological mechanism involving oxidative stress (Davinelli, et al 2024). Iran is home to more than 850 Astragalus species, including 527 endemic varieties (Ghasemian-Yadegari et al., 2017; Aslanipour et al., 2017). As an adaptogen, Astragalus helps the body respond to stress and maintain internal balance (Liao et al., 2018; Oh et al., 2014).
Although few clinical studies exist, preclinical research shows adaptogens may reduce anxiety and improve sleep (Pawar & Shivakumar, 2012; Panossian & Wikman, 2010; Di Liberto et al., 2017; Fedotova et al., 2017; Salve et al., 2019). Astragalus supports immune modulation, adrenal balance, inflammation reduction, chronic fatigue syndrome, and cognitive function (Peng et al., 2022; Abd Elkader et al., 2021; Jalsrai et al., 2010; Zhang et al., 2022; Bahaeddin et al., 2018; Banihashemi et al., 2025). It has also shown efficacy in restoring intestinal balance, which influences sleep health (Li et al., 2023).
Given the ongoing mental health challenges faced by nurses post-COVID-19—and the paucity of studies evaluating herbal interventions—the present research investigated whether Astragalus root extract (ARE) could reduce anxiety and improve sleep among nurses. The study was guided by the hypothesis that ARE consumption would offer measurable psychological benefits in this vulnerable population.
Materials and Methods
Design and setting: This study was carried out as a randomized, triple-blind, placebo-controlled trial conducted on nurses at two educational hospitals in Kashan, Iran, in 2023. The study was conducted in a parallel design, with samples allocated one-to-one to each group. The present study was reported based on consolidated standards of reporting trials (CONSORT) guidelines for herbal medicines.
Participants: Inclusion criteria included consent to participate in the study; a history of COVID-19 infection, with at least 6 and a maximum of 12 months having passed since the infection; employment as a nurse in a hospital; no use of anticoagulants; no experience of orthostatic hypotension or allergic reactions to vegetables or beans; not being under the influence of antipsychotics or antidepressants; and no thyroid dysfunction. Exclusion criteria were unwillingness to continue participation, discontinuation of medication for four consecutive days, use of anti-anxiety or sleeping pills during the study, pregnancy, occurrence of drug allergy symptoms, or experiencing hypotensive reactions.
Sample size: According to the research hypothesis and the parallel design of the study, the sample size was estimated using the formula for calculating the sample size in experimental studies (
Equation 1). Based on the results of the study by Tingting et al. (2022), the sample size was calculated as 29, considering a mean difference of 5.83, variance of 11, a type I error of 0.05, and a type II error of 0.2. Accounting for a 10% attrition rate, 32 subjects were considered for each group.
1. n1=n2=(z1-α/2+z1-β)2 δ2/(d2)≈29
Recruitment and randomization: Participants were randomly selected from the medical, surgical, emergency, and critical care departments of two educational hospitals by drawing lots and based on the quota of each department. They were assigned to either the intervention or control group by the principal investigator using stratified random block methods. Stratified block randomization was performed with a block size of four, generated by the online Sealedenvelope software. Considering that gender may influence the outcomes, the two groups were matched based on this variable.
Blinding: This study was conducted as a triple-blind trial. The participants, the prescribing physician, and the statistical analyst—all members of the research team—were blinded to the group assignments. Only the principal investigator, who prepared the packages and held the randomization list, was aware of the identities of the intervention and control groups.
Intervention: The powdered extract used in this study was obtained from the root of Astragalus. The product was processed in distilled form and prepared in 500 mg capsules by Asha Organic Company. For the placebo group, cornstarch was encapsulated in capsules identical to those used in the intervention group. Participants were instructed on the proper use of the ARE and were administered 500 mg capsules twice daily (morning and evening) for 30 days. The control group received identical capsules containing 500 mg of corn starch, also taken twice daily for 30 days.
Throughout the intervention, potential side effects were monitored by daily phone calls during the first week and weekly calls thereafter. The researcher’s mobile phone number was also provided; thus, participants could report any side effects or concerns. No severe adverse effects were observed. A few participants in the intervention group reported mild heartburn and gastric sourness within the first hour of administration during the initial days of treatment; however, these symptoms resolved spontaneously in subsequent days. In consultation with the study’s co-investigator (Mehdi Rajabi), it was determined that no medication was required, and participants were simply advised to drink an additional glass of water at the time of capsule intake, which alleviated the problem.
The powder extract used in this study, which was obtained from the root of the Astragalus verus species, was tested for the phytochemical constituents. As a result of this test, carbohydrates, proteins, amino acids, glycosides, saponins, volatile oils, alkaloids, sterols, and flavonoids were found (Abdallah et al, 2024). Studies have shown no signs of toxicity in rats even with a maximum dose of 2000 mg/kg of the extract during 14 days. The oral lethal dose (LD50) cut off value of the ethanolic extract of A. membranaceus is 5000 mg/kg, indicating it is safe for use (Pathak, 2022).
Instruments
Demographic information form: The subjects were asked about their age, sex, work experience, marital status, department, number of working hours per month, number of children, level of education, and history of COVID-19.
The Pittsburgh sleep quality index (PSQI): This is a self-report instrument designed to evaluate sleep quality over a one-month period. It consists of 18 items grouped into seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each component is scored from 0 to 3, yielding a global score ranging from 0 to 21. A score greater than 5 indicates poor sleeper, while others are recognized as good (Buysse et al., 1989). The PSQI is widely used due to its simplicity, reliability, and validity, offering a comprehensive assessment of sleep across multiple dimensions (Bastani & Amirijavid, 2023). The original version demonstrated strong internal consistency, test re-test reliability, and validity, with diagnostic sensitivity of 89.6% and specificity of 86.5%. Cronbach’s α values reported in different studies range from 0.78 to 0.89, confirming its reliability across populations, including Persian adaptations. Content validity has also been established through expert review. Soleimany et al, examined the validity and reliability of the Persian version of the PSQI and reported a Cronbach’s α of 0.87 (Soleimany et al, et al, 2007). The reliability of the questionnaire in this study was assessed using internal consistency, yielding a Cronbach’s α of 0.83.
The Beck anxiety inventory (BAI): In 1988, Aaron Beck introduced this inventory to measure the severity of clinical symptoms of anxiety. This 21-item self-assessment tool measures anxiety symptoms on a 4-point Likert scale (0=not at all, 1=mildly, 2=moderately, and 3=severely). The scores range from 0 to 63. On this scale, 0–7 indicates minimal anxiety, 8–15 mild anxiety, 16–25 moderate anxiety, and 26–63 severe anxiety (Jalilvandi et al., 2025). Its internal consistency (α coefficient) was 0.92, and its reliability was assessed as 0.75 using the test-retest method within a one-week interval. The correlation between items varied from 0.30 to 0.76 (Beck et al., 1988). This questionnaire was translated into Persian in 2005, with a reported reliability of 0.74 (Ghassemzadeh et al., 2005). In this study, the internal consistency (Cronbach’s α) of the scale was estimated at 0.9.
Data collection: Nurses were selected from a list of names available in the nursing office and were informed of the study’s objectives. Those who agreed to participate were provided with the research tools. The researcher responsible for collecting information arranged with participants in advance to complete the questionnaires at their convenience. Participants were allowed to complete the questionnaires during their break time at the hospital or at home. An initial assessment was conducted prior to the administration of ARE (time 1: T1), followed by a second assessment 30 days after the administration (time 2: T2), and a third assessment 60 days afterward (time 3: T3).
Data analysis: Data analysis was performed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics were used to summarize the socio-demographic and clinical characteristics of each study group. The Kolmogorov-Smirnov test was used to determine normal distribution of the variables. Independent t-tests, chi-square tests, and one-way analysis of variance (ANOVA) were used to compare demographic variables between the two groups. Repeated measures analysis of variance (ANOVA) and independent samples t-tests were used to analyze the mean scores of anxiety and sleep quality at T1, T2, and T3. The Bonferroni post hoc test was also used for pairwise comparisons within groups. The generalized estimating equations (GEE) approach was also used to examine the effect of confounding variables on sleep quality. The level of significance for statistical tests was set at P<0.05 (2-tailed). A complete-case analysis approach was used for missing data; in this approach, participants with missing data were excluded from the analysis (Josheghani et al., 2024). Data from 29 participants in the intervention group and 30 participants in the control group were analyzed.
Results
During the study, three subjects in the intervention group (two due to tiredness and one due to hospitalization because of tibia fracture) and two subjects in the control group (one due to tiredness and one because of forgetting to take medicine) were excluded from the study. These questionnaires were not included in the analysis. Finally, data from 29 and 30 nurses in the intervention and control groups, respectively, were analyzed (
Figure 1).
The intervention and control groups differed significantly only in the number of children, while no significant differences were observed for the other variables (
Table 1).

There were no significant differences between groups regarding sleep quality and anxiety at T1 (P>0.05). According to the results of the independent samples t-test, there was a statistically significant difference between the mean score of sleep quality in the ARE and control groups at T2 and T3 (P<0.05). As shown by the repeated measures ANOVA, the changes in sleep quality scores in the ARE group were significant (P<0.001), and the Bonferroni post-hoc test also confirmed this significance between T1 and T2, as well as between T1 and T3. The results indicated a statistically significant difference over time between the two groups (P<0.05;
Table 2).

The independent samples t-test also revealed a statistically significant difference between the mean anxiety scores of the ARE and control groups at T2 and T3 (P<0.05). The repeated measures ANOVA indicated significant changes in the anxiety scores of nurses in the ARE group (P<0.001). In addition, the Bonferroni post-hoc test showed a significant difference between T1 and T2, as well as T1 and T3. There was also a significant difference between the two groups over time (P<0.05;
Table 3).

To assess the impact of confounding variables on anxiety and sleep quality, the GEE approach was used, with confounders (department and history of COVID-19 infection) entered stepwise. After controlling for these variables, no significant difference in mean anxiety scores was found between the intervention and control groups (β=5.60, SE=3.02, P=0.064;
Table 4), but the intervention group showed a significantly different trend in anxiety reduction over time (β=-3.78, SE=1.05, P=0.0001;
Table 4).

Nurses in medical (β=5.19, SE=2.09, P=0.01;
Table 4) and critical care (β=6.33, SE=2.58, P=0.01;
Table 4) departments, and those with more frequent COVID-19 infections (β=1.28, SE=0.56, P=0.02;
Table 4), had higher anxiety scores compared to those in the emergency department. For sleep quality, no significant group difference was observed (β=-0.20, SE=1.07, P=0.84;
Table 5), but the intervention group exhibited significant improvement over time (β=-0.74, SE=0.34, P=0.03;
Table 5).
Discussion
The use of ARE demonstrated notable effectiveness in improving sleep quality and reducing anxiety among nurses affected by COVID-19. Over time, nurses in the ARE group showed statistically significant improvement in sleep scores, whereas the control group exhibited minimal change. This finding aligns with earlier research indicating the sleep-enhancing properties of Astragalus species (Shahrajabian et al., 2019). Li et al. (2023) reported that polysaccharides from Astragalus help alleviate age-related sleep disorders, and Huang et al. (2019) found improvements in quality-of-life indicators, including disturbed sleep. Zhang et al. (2013) found that Astragalus reduced hippocampal neuron apoptosis and oxidative markers while increasing protective enzymes, like superoxide dismutase (SOD). Astragalus has also helped restore gut microbiota balance, which may support sleep regulation (Li et al., 2023).
Phytochemicals within Astragalus—including flavonoids, saponins, and polysaccharides—play a key role in its therapeutic effects (Sun et al., 2018). Saponins have been shown to extend sleep duration in animal studies (Jiang et al., 2007), while polysaccharides are linked to oxidative stress reduction and improved sleep via enhanced tricarboxylic acid cycle activity and neurotoxin elimination (Niu et al., 2018; Shao et al., 2004).
Interestingly, the control group also experienced a mild reduction in sleep disorder over time. Although no active substance was administered, psychological effects related to the placebo may explain these improvements. Previous research has documented psychological influence resulting from placebo use (Lindheimer et al., 2020), and the natural passage of time could also be a contributing factor.
Beyond sleep, ARE significantly lowered anxiety levels of nurses recovering from COVID-19, with sustained effects for up to a month post-intervention. Similar anxiolytic benefits have been observed in animal models using Astragaloside IV and Astragalus spinosus saponins (Abd Elkader et al., 2021; Oh et al., 2014). Other studies further support the neuroprotective and anti-anxiety effects of Astragalus (Jalsrai et al., 2019; Molodavkin et al., 1998; Bottles, 2022; Park et al., 2009; Yuan et al., 2024).
Anxiety is a multifaceted emotional response driven by neurotransmitter imbalance and dysfunction in key brain regions, such as the prefrontal cortex and hippocampus (Farb & Ratner, 2014). It involves altered signaling in serotonin, dopamine, and cannabinoid systems (Akter et al., 2020). Components, like polysaccharides and saponins target these pathways and may relieve anxiety symptoms. Polysaccharides are recognized for their biological versatility and have shown anxiolytic activity in various models (Cui et al., 2013; Wang et al., 2018; Akter et al., 2020). Similarly, saponins and other plant-derived compounds, like flavonoids and terpenes show calming effects and influence key stress-related mechanisms (Savage et al., 2018; Hosein Farzaei et al., 2016).
Stress activates the hypothalamo-pituitary-adrenal (HPA) axis, resulting in increased corticosterone and adrenocorticotropic hormone levels. Certain phytochemicals, including Astragalus polysaccharides, may modulate these responses. For instance, Ma et al. (2023) demonstrated a decrease in these hormones in rats, suggesting mood-stabilizing potential. The anxiolytic effects of ARE may also be related to interaction with GABA/benzodiazepine receptors, potentially explaining its influence on behavior and locomotor activity (Jalsrai et al., 2010).
The study yielded promising findings. However, the psychological conditions of the samples, which could be caused by forced overtime and irregular night shifts, were beyond the researchers’ control and may have affected the results.
Conclusion
Using ARE can have a positive effect on sleep quality and reduce anxiety in nurses suffering from COVID-19. Therefore, it can be used alongside other therapies to treat sleep disorders and anxiety in this group. To increase the generalizability of the results, more extensive research is needed to examine the effects of this extract on hormone levels.
Ethical Considerations
Compliance with ethical guidelines
This Study was approved by the Research Ethics Committee of Kashan University of Medical Sciences, Kashan, Iran (Code: IR.KAUMS.NUHEPM.REC.1401.088). Participants were informed that declining the invitation or withdrawing from the study at any time would have no negative consequences. They provided written informed consent and were assured that their personal information would be kept confidential. The research was conducted in accordance with the Declaration of Helsinki. The research proposal for this manuscript has been registered with the Iranian Registry of Clinical Trials (IRCT) (Code: IRCT20100124003146N11) on March 1, 2023.
Funding
This study was supported by Kashan University of Medical Sciences, Kashan, Iran (Grant No.: 401164).
Authors' contributions
Conceptualization and methodology: Ismail Azizi-Fini, Safoura Yadollahi, Zahra-Sadat Banihashemi, and Mehdi Rajabi; Investigation and project administration: Ismail Azizi-Fini; Formal analysis: Safoura Yadollahi and Mahboobeh Maghami; Funding acquisition: Ismail Azizi-Fini, Safoura Yadollahi, Zahra-Sadat Banihashemi, and Mehdi Rajabi; Supervision: Safoura Yadollahi; Writing the original draft: Safoura Yadollahi, Zahra-Sadat Banihashemi, and Mahboobeh Maghami; Review, editing and final approval: All authors.
Conflict of interest
The authors declared no conflict of interest.
Acknowledgments
The researchers would like to thank and appreciate all those who assisted with the research, including the officials of the university, the Clinical Research Development Unit of Shahid-Beheshti Hospital, and all the nurses involved.
References
Abdallah, W.E., et al., 2024. Phytochemical and biological investigation of Astragalus Caprinus L. BMC Complementary Medicine and Therapies, 24(1), pp. 294. [DOI:10.1186/s12906-024-04484-4] [PMID]
Abd Elkader, H. A. E., et al., 2021. Anti-anxiety and antidepressant-like effects of astragaloside IV and saponins extracted from Astragalus spinosus against the bisphenol A-induced motor and cognitive impairments in a postnatal rat model of schizophrenia. Environmental Science and Pollution Research International, 28(26), pp. 35171–87. [DOI:10.1007/s11356-021-12927-5] [PMID]
Akter, S., et al., 2020. Gamma oryzanol impairs alcohol-induced anxiety-like behavior in mice via upregulation of central monoamines associated with Bdnf and Il-1β signaling. Scientific Reports, 10(1), pp. 10677. [DOI:10.1038/s41598-020-67689-w] [PMID]
Amiri, A., et al., 2021. [Investigating the level of job stress in nurses exposed to covid-19 in educational hospitals in Ahvaz (Persian)]. Journal of Occupational Hygiene Engineeringg, 8(2), pp. 58-65. [DOI:10.52547/johe.8.2.58]
Asadi, N., Memarian, R. & Vanaki, Z., 2019. Motivation to care: A qualitative study on Iranian nurses. The Journal of Nursing Research : JNR, 27(4), pp. e34. [DOI:10.1097/jnr.0000000000000294] [PMID]
Aslanipour, B., et al., 2017. Cycloartane-type glycosides from Astragalus brachycalyx FISCHER and their effects on cytokine release and hemolysis. Phytochemistry Letters, 21, pp. 66-73. [DOI:10.1016/j.phytol.2017.05.028]
Bahaeddin, Z., et al., 2018. Dietary supplementation with Allium hirtifolium and/or Astragalus hamosus improved memory and reduced neuro-inflammation in the rat model of Alzheimer’s disease. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme, 43(6), pp. 558–64. [DOI:10.1139/apnm-2017-0585] [PMID]
Banihashemi, Z. S., et al., 2025. Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract. BMJ Supportive & Palliative Care, 30;15(3), pp. 359-66. [DOI:10.1136/spcare-2023-004595] [PMID]
Bastani, F. & Amirijavid, A., 2023. Sleep quality in the survivors of COVID-19. Journal of Client-Centered Nursing Care, 9(3), pp. 199-206. [DOI:10.32598/JCCNC.9.3.447]
Beck, A. T., et al., 1988. An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), pp. 893–7. [DOI:10.1037//0022-006x.56.6.893] [PMID]
Buysse, D. J., et al., 1989. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), pp. 193–213. [DOI:10.1016/0165-1781(89)90047-4] [PMID]
Chen, Y., et al., 2022b. Meta-analysis of the prevalence of anxiety and depression among frontline healthcare workers during the COVID-19 pandemic. Frontiers in Public Health, 10, pp. 984630. [DOI:10.3389/fpubh.2022.984630] [PMID]
Cohen, S. D., Cukor, D. & Kimmel, P. L., 2016. Anxiety in patients treated with hemodialysis. Clinical Journal of The American Society of Nephrology : CJASN, 11(12), pp. 2250–5. [DOI:10.2215/CJN.02590316] [PMID]
Crocq, M. A., 2015. A history of anxiety: From hippocrates to DSM. Dialogues in Clinical Neuroscience, 17(3), pp.319–25. [DOI:10.31887/DCNS.2015.17.3/macrocq] [PMID]
Cui, Y., et al., 2013. Mechanism-based anti-anxiety effects of polysaccharides extracted from shudihuang (radix rehmanniae preparata) by two-dimensional electrophoresis analysis in rat hippocampus proteins. Journal of Traditional Chinese Medicine, 33(4), pp. 524–30. [DOI:10.1016/S0254-6272(13)60159-4] [PMID]
Davinelli, S., et al., 2024. Sleep and Oxidative Stress: Current Perspectives on the Role of NRF2. Cellular and Molecular Neurobiology, 44(1), pp. 52. [DOI:10.1007/s10571-024-01487-0] [PMID]
De Pinho, L. G., et al., 2021. Portuguese nurses’ stress, anxiety, and depression reduction strategies during the covid-19 outbreak. International Journal of Environmental Research and Public Health, 18(7), pp. 3490. [DOI:10.3390/ijerph18073490] [PMID]
Di Liberto, V., et al., 2017. Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex. Psychopharmacology, 234, pp. 559-73. [DOI:10.1007/s00213-016-4498-0] [PMID]
Farb, D. H. & Ratner, M. H., 2014. Targeting the modulation of neural circuitry for the treatment of anxiety disorders. Pharmacological Reviews, 66(4), pp. 1002–32. [DOI:10.1124/pr.114.009126] [PMID]
Fedotova, J., et al., 2017. Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts. Biomedicine & Pharmacotherapy, 95, 437-46. [DOI:10.1016/j.biopha.2017.08.107] [PMID]
Ghassemzadeh, H., et al., 2005. Psychometric properties of a Persian‐Language version of the Beck depression inventory‐second edition: BDI‐II‐PERSIAN. Depression and Anxiety, 21(4), pp. 185-92. [DOI:10.1002/da.20070] [PMID]
Ghasemian-Yadegari, J., et al., 2017. Secondary metabolites from the roots of Astragalus maximus. Research Journal of Pharmacognosy, 4(2), pp. 31-8. [Link]
Farzaei, M., et al., 2016. A systematic review of plant-derived natural compounds for anxiety disorders. Current Topics in Medicinal Chemistry, 16(17), pp. 1924–42. [DOI:10.2174/1568026616666160204121039] [PMID]
Hoseinabadi, T., et al., 2020. Burnout and its influencing factors between frontline nurses and nurses from other wards during the outbreak of coronavirus disease-COVID-19-in Iran. Investigacion y Educacion en Enfermeria, 38(2), pp. e3. [DOI:10.17533/udea.iee.v38n2e03] [PMID]
Huang, L., et al., 2020. Nurses’ sleep quality of “Fangcang” hospital in China during the COVID-19 pandemic. International Journal of Mental Health and Addiction, 20(2), pp. 789–99. [DOI:10.1007/s11469-020-00404-y] [PMID]
Huang, W. C., et al., 2019. Astragalus polysaccharide (PG2) ameliorates cancer symptom clusters, as well as improves quality of life in patients with metastatic disease, through Modulation of the inflammatory cascade. Cancers, 11(8), pp. 1054. [DOI:10.3390/cancers11081054]
Jahrami, H., et al., 2021. The examination of sleep quality for frontline healthcare workers during the outbreak of COVID-19. Sleep & Breathing = Schlaf & Atmung, 25(1), pp. 503–11. [DOI:10.1007/s11325-020-02135-9] [PMID]
Jalilvandi, A., Sheikhi M. R. & Khodabakhshi-Koolaee, A., 2025. Investigating how the Benson relaxation response reduces anxiety in mothers of children with autism spectrum disorder. Journal of Client-Centered Nursing Care, 11(1), pp. 45-54. [DOI:10.32598/JCCNC.11.1.617]
Jalsrai, A., et al., 2019. Neuropsychopharmacological profile of Astragalus membranaceous var. mongholicus. Journal of Traditional Chinese Medical Sciences, 6(3), pp. 254-62. [DOI:10.1016/j.jtcms.2019.08.002]
Jalsrai, A., Grecksch, G. & Becker, A., 2010. Evaluation of the effects of Astragalus mongholicus Bunge saponin extract on central nervous system functions. Journal of Ethnopharmacology, 131(3), pp. 544–9. [DOI:10.1016/j.jep.2010.07.031] [PMID]
Jiang, J. G., et al., 2007. Comparison of the sedative and hypnotic effects of flavonoids, saponins, and polysaccharides extracted from Semen Ziziphus jujube. Natural Product Research, 21(4), pp. 310–20. [DOI:10.1080/14786410701192827] [PMID]
Josheghani, M. A., et al., 2024. The effects of auriculotherapy on depression among elderly people: A randomized controlled clinical trial. Complementary Therapies in Medicine, 83, pp. 103054. [DOI:10.1016/j.ctim.2024.103054] [PMID]
Khalafi-Kheydani, A., et al., 2022. The effect of nettle root extract on urinary problems in older men with benign prostatic hyperplasia: A randomized clinical trial. Journal of Herbal Medicine, 34, pp. 100568. [DOI:10.1016/j.hermed.2022.100568]
Lasalvia, A., et al., 2021. Levels of burn-out among healthcare workers during the COVID-19 pandemic and their associated factors: a cross-sectional study in a tertiary hospital of a highly burdened area of north-east Italy. BMJ Open, 11(1), pp. e045127. [DOI:10.1136/bmjopen-2020-045127] [PMID]
Li, X., et al., 2023. Regulation and mechanism of Astragalus polysaccharide on ameliorating aging in Drosophila melanogaster. International Journal of Biological Macromolecules, 234, pp. 123632. [DOI:10.1016/j.ijbiomac.2023.123632] [PMID]
Liao, L. Y., et al., 2018. A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide. Chinese Medicine, 13, pp. 57. [DOI:10.1186/s13020-018-0214-9] [PMID]
Lindheimer, J. B., et al., 2020. Advancing the understanding of placebo effects in psychological outcomes of exercise: Lessons learned and future directions. European Journal of Sport Science, 20(3), pp. 326–37. [DOI:10.1080/17461391.2019.1632937] [PMID]
Ma, M., et al., 2023. The anxiolytic effect of polysaccharides from Stellariae radix through monoamine neurotransmitters, HPA axis, and ECS/ERK/CREB/BDNF signaling pathway in stress-induced male rats. Brain Research Bulletin, 203, pp. 110768. [DOI:10.1016/j.brainresbull.2023.110768] [PMID]
Mira, J. J., et al., 2020. Acute stress of the healthcare workforce during the COVID-19 pandemic evolution: A cross-sectional study in Spain. BMJ Open, 10(11), pp. e042555. [DOI:10.1136/bmjopen-2020-042555] [PMID]
Maghami, M., et al., 2024. Pain and sleep after open-heart surgery-inhalation peppermint essence: Double-blind randomized clinical trial. BMJ Supportive & Palliative Care, 13(e3), pp. e1318-25. [DOI:10.1136/spcare-2023-004214] [PMID]
Molodavkin, G. M., et al., 1998. Behavioral and electrophysiological analysis of anxiolytic effect of Mongolian astragalus. Bulletin of Experimental Biology and Medicine, 125, pp. 358-60. [DOI:10.1007/BF02499157]
Soleimany, M., et al., 2007. [(Persian) Comparison of sleep quality in two groups of nurses with and without rotation work shift hours]. Iran Journal of Nursing, 20 (49) pp. 29-38. [Link]
Niu, X., et al., 2018. The investigation of immunoprotective and sedative hypnotic effect of total polysaccharide from Suanzaoren decoction by serum metabonomics approach.Journal of Chromatography. B, Analytical Technologies in The Biomedical and Life Sciences, 1086, pp. 29–37. [DOI:10.1016/j.jchromb.2018.04.004] [PMID]
Oh, H. A., et al., 2014. Anti-stress effect of astragaloside IV in immobilized mice. Journal of Ethnopharmacology, 153(3), pp. 928–32. [DOI:10.1016/j.jep.2014.03.068] [PMID]
Panossian, A. & Wikman, G., 2010. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals, 3(1), pp. 188-224. [DOI:10.3390/ph3010188] [PMID]
Pappa, S., et al., 2020. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 88, pp. 901-7. [DOI:10.1016/j.bbi.2020.05.026]
Park, H. J., et al., 2009. The Effects of Astragalus Membranaceus on Repeated Restraint Stress-induced Biochemical and Behavioral Responses. The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology, 13(4), pp. 315–9. [DOI:10.4196/kjpp.2009.13.4.315] [PMID]
Patel, K., et al., 2016. Bupropion: A systematic review and meta-analysis of effectiveness as an antidepressant. Therapeutic Advances in Psychopharmacology, 6(2), pp. 99–144. [DOI:10.1177/2045125316629071] [PMID]
Pathak, L., 2022. Acute toxicity test and nootropic activity of ethanolic extract of Astragalus membranaceus Bunge on scopolamine-induced amnesia in rats. Journal of Drug Delivery and Therapeutics, 12(2), pp. 11-18. [DOI:10.22270/jddt.v12i2.5230]
Pawar, V. S. & Shivakumar, H., 2012. A current status of adaptogens: Natural remedy to stress. Asian Pacific Journal of Tropical Disease, 2(Supplement 1), pp. S480-90. [DOI:10.1016/S2222-1808(12)60207-2]
Peng, X., et al., 2022. Bidirectional effects and mechanisms of traditional Chinese medicine. Journal of Ethnopharmacology, 298, pp. 115578. [DOI:10.1016/j.jep.2022.115578] [PMID]
Qiu, D., et al., 2020. Prevalence of sleep disturbances in Chinese healthcare professionals: A systematic review and meta-analysis. Sleep Medicine, 67, pp. 258–66. [DOI:10.1016/j.sleep.2019.01.047] [PMID]
Salaree, M. M., Rahmati, F. & Parandeh, A., 2022. Comparison of sleep quality and its related factors in nurses before and at the same time with the COVID-19 epidemic. Journal of Military Medicine, 23, pp. 395-403. [Link]
Salari, N., et al., 2020. The prevalence of sleep disturbances among physicians and nurses facing the COVID-19 patients: a systematic review and meta-analysis. Global Health, 16(1), pp. 92. [DOI:10.1186/s12992-020-00620-0] [PMID]
Salve, J., et al., 2019. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus, 11(12), pp. e6466. [DOI:10.7759/cureus.6466] [PMID] [PMCID]
Savage, K., et al., 2018. GABA‐modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence. Phytotherapy Research: PTR, 32(1), pp. 3–18. [DOI:10.1002/ptr.5940] [PMID]
Shahrajabian, M., Sun, W. & Cheng, Q., 2019. A Review of Astragalus Species as Foodstuffs, Dietary Supplements, a Traditional Chinese Medicine and a Part of Modern Pharmaceutical Science. Applied Ecology and Environmental Research, 17(6), pp. 13371-82. [DOI:10.15666/aeer/1706_1337113382]
Shao, B. M., et al., 2004. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochemical and Biophysical Research Communications, 320(4), pp. 1103–11. [DOI:10.1016/j.bbrc.2004.06.065] [PMID]
Sharifi, A., et al., 2022. Depression, anxiety, and stress among Iranian nurses in COVID-19 care wards. BMC Psychology, 10(1), pp. 205. [DOI:10.1186/s40359-022-00911-8] [PMID]
Simonetti, V., et al., 2021. Anxiety, sleep disorders and self-efficacy among nurses during COVID-19 pandemic: A large cross-sectional study. Journal of Clinical Nursing, 30(9-10), pp. 1360–71. [DOI:10.1111/jocn.15685] [PMID]
Sun, J., et al., 2018. Extraction methods and sedative-hypnotic effects of polysaccharide and total flavonoids of Cordyceps militaris. Biotechnol Biotechnol Equipment, 32(2), pp. 498-505. [DOI:10.1080/13102818.2017.1336942]
Tingting MA, et al., 2022. Ginger-indirect moxibustion plus acupuncture versus acupuncture alone for chronic fatigue syndrome: a randomized controlled trial. Journal of traditional Chinese Medicine 42, 242-9. [DOI:10.19852/j.cnki.jtcm.20211214.003] [PMID]
Wang, J., et al., 2018. Metabonomics approach to comparing the antistress effects of four Panax ginseng components in rats. Journal of Proteome Research, 17(2), pp. 813–21. [DOI:10.1021/acs.jproteome.7b00559] [PMID]
Yuan, J., et al., 2024. Exploring the mechanism of Astragalus membranaceus in the treatment of post-infectious irritable bowel syndrome based on random walk with restart algorithm and experimental validation. Journal of Experimental and Clinical Application of Chinese Medicine, 5(2), pp. 22-35. [DOI:10.62767/jecacm502.0420]
Zhang, Q., et al., 2013. Protective effects of astragalus extract against intermittent hypoxia-induced hippocampal neurons impairment in rats. Chinese Medical Journal, 126(8), pp. 1551–4. [DOI:10.3760/cma.j.issn.0366-6999.20122722] [PMID]
Zhang, Y., et al., 2022. Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice. Frontiers in Aging Neuroscience, 14, pp. 1004557. [DOI:10.3389/fnagi.2022.1004557] [PMID]